Skip to main content
Erschienen in: Advances in Therapy 1/2020

09.11.2019 | Original Research

Clinical Analysis of 122 Cases with Mycoplasma Pneumonia Complicated with Atelectasis: A Retrospective Study

verfasst von: De-Quan Su, Jin-Fan Li, Zhi-Qiang Zhuo

Erschienen in: Advances in Therapy | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

This study aims to explore the clinical characteristics, treatment, and prognosis of mycoplasma pneumonia complicated with atelectasis.

Methods

A retrospective analysis was performed on 122 children with mycoplasma pneumonia complicated with atelectasis. These children were hospitalized in the Xiamen Campus of the Pediatric Hospital of Fudan University and the Children’s Hospital of Xiamen between December 2015 and December 2018. A diagnosis was made for each case on the basis of the clinical symptoms and signs, Mycoplasma pneumoniae-specific IgM antibody, and imaging results.

Results

Among the 122 cases with mycoplasma pneumonia complicated with atelectasis, all cases had retractable M. pneumoniae infection, 102 cases underwent fibrobronchoscopic lavage treatment, and all cases were treated with macrolide antibiotics after a definite diagnosis was made. Furthermore, 107 cases improved and were discharged. Follow-up was performed for 3–4 weeks for all patients, and all patients, including the five cases with retractable disease, recovered well.

Conclusion

The major clinical manifestations for M. pneumoniae pneumonia are fever and stimulatory dry cough. Macrolide antibiotics remain the treatment of choice.
Literatur
2.
Zurück zum Zitat Hu YM, Jiang ZF, Shen KL, Shen Y. Chu Futang practical pediatrics. 8th ed. Beijing: Beijing People’s Medical Publishing Press; 2015. p. 1280–2 (In Chinese). Hu YM, Jiang ZF, Shen KL, Shen Y. Chu Futang practical pediatrics. 8th ed. Beijing: Beijing People’s Medical Publishing Press; 2015. p. 1280–2 (In Chinese).
11.
Zurück zum Zitat Grabowska-Krawiec P. Contemporary risks of infections by Mycoplasma pneumoniae and Chlamydophila pneumoniae. Pol Merkur Lekarski. 2012;33(197):270–3.PubMed Grabowska-Krawiec P. Contemporary risks of infections by Mycoplasma pneumoniae and Chlamydophila pneumoniae. Pol Merkur Lekarski. 2012;33(197):270–3.PubMed
13.
Zurück zum Zitat Rey JW, Deris N, Marquardt JU, et al. High-definition endoscopy with iScan and Lugol’s solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group. Dis Esophagus. 2016;29(2):185–91. https://doi.org/10.1111/dote.12308.CrossRefPubMed Rey JW, Deris N, Marquardt JU, et al. High-definition endoscopy with iScan and Lugol’s solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group. Dis Esophagus. 2016;29(2):185–91. https://​doi.​org/​10.​1111/​dote.​12308.CrossRefPubMed
17.
Zurück zum Zitat Ma EL, Wang C, Wang MW. Advances in research on immune-regulatory effects of macrolide antibiotics. World Notes Antibiot. 2003;1:1–4 (In Chinese). Ma EL, Wang C, Wang MW. Advances in research on immune-regulatory effects of macrolide antibiotics. World Notes Antibiot. 2003;1:1–4 (In Chinese).
21.
Zurück zum Zitat Zhuo Z, Li F, Chen X, Jin P, Guo Q, Wang H. Mycoplasma pneumonia combined with pulmonary infarction in a child. Int J Clin Exp Med. 2015;8(1):1482–6.PubMedPubMedCentral Zhuo Z, Li F, Chen X, Jin P, Guo Q, Wang H. Mycoplasma pneumonia combined with pulmonary infarction in a child. Int J Clin Exp Med. 2015;8(1):1482–6.PubMedPubMedCentral
Metadaten
Titel
Clinical Analysis of 122 Cases with Mycoplasma Pneumonia Complicated with Atelectasis: A Retrospective Study
verfasst von
De-Quan Su
Jin-Fan Li
Zhi-Qiang Zhuo
Publikationsdatum
09.11.2019
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 1/2020
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-019-01129-8

Weitere Artikel der Ausgabe 1/2020

Advances in Therapy 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.